https://doctransparency.com/doctor/tx/denton/diana-castro-1750554689
Medicare Enrolled

Dr. Diana Castro, MD

Student in an Organized Health Care Education/Training Program · Denton, TX
Consulting-driven
2817 S MAYHILL RD STE 115, Denton, TX 76208
9726342931
In practice since 2008 (17 years)
NPI: 1750554689 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Castro from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Castro? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Castro

Dr. Diana Castro is a student in an organized health care education/training program in Denton, TX, with 17 years in practice.

Between the years covered by Open Payments, Dr. Castro received a total of $378,807 from 25 pharmaceutical and/or device companies across 326 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Castro is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice$ $378,807 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$378,807
Total received (2018-2024)
Avg $54,115/year across 7 years
Top 0% in TX for student in an organized health care education/training program
25
Companies
326
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$316,869 (83.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$59,342 (15.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,596 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$48,692
2023
$21,221
2022
$80,659
2021
$44,676
2020
$68,689
2019
$42,384
2018
$72,486

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Biogen, Inc.
$178,446
Sarepta Therapeutics, Inc.
$59,405
PTC Therapeutics, Inc.
$50,368
Genentech USA, Inc.
$26,294
Novartis Gene Therapies, Inc. (fka AveXis, Inc.)
$17,080
Genentech, Inc.
$11,192
PFIZER INC.
$9,297
Novartis Pharmaceuticals Corporation
$6,721
ITF Therapeutics LLC
$4,264
CATALYST PHARMACEUTICALS, INC.
$3,766
AveXis
$3,667
Janssen Research & Development, LLC
$2,750
NS Pharma, Inc.
$1,904
F. Hoffmann-La Roche AG
$1,566
Takeda Pharmaceuticals U.S.A., Inc.
$1,510
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)
$105
Grifols USA, LLC
$98
SANOFI-AVENTIS U.S. LLC
$80
ARGENX US, INC.
$69
NeuroLogica Corporation, a subsidiary of Samsung Electronics Co., Ltd.
$50
Sunovion Pharmaceuticals Inc.
$48
GENZYME CORPORATION
$47
Boston Scientific Corporation
$33
Grifols Shared Services North America, Inc.
$31
CSL Behring
$16
Top 3 companies account for 76.1% of total payments
Associated products mentioned in payments ›
AGAMREE · APTIOM · EMFLAZA · EXONDYS 51 · Elevidys · Evrysdi · Exondys 51 · FABRAZYME · Gamunex-C · HM70 · HYQVIA · Hizentra · NEXVIAZYME · Non-Covered Product · QALSODY · SPINRAZA · Skyclarys · TYSABRI · VABYSMO · VILTEPSO · VYVGART · WaveWriter Alpha Prime 16 · ZOLGENSMA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (84%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for student in an organized health care education/training program in TX.

Looking for a student in an organized health care education/training program in Denton?
Compare student in an organized health care education/training programs in the Denton area by procedure volume, costs, and industry payment transparency.
Browse student in an organized health care education/training programs nearby

Geographic Context

Student in an Organized Health Care Education/Training Programs within 10 mi
700
Per 100K population
74.0
County median income
$108,185
Nearest hospital
THE HEART HOSPITAL BAYLOR DENTON
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Castro is a student in an organized health care education/training program, and high industry engagement (consulting-driven, top 0%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Castro receive payments from pharmaceutical companies?
Yes. Dr. Castro received a total of $378,807 from 25 companies across 326 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Castro) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →